Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Kutok joins Epizyme as CSO; plus ADC Therapeutics, Emulate, E-Scape, MiMedx and RubrYc

March 21, 2020 12:50 AM UTC

Epizyme Inc. (NASDAQ:EPZM) hired Jeffery Kutok as CSO. He was EVP and CSO of Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Kutok joins the epigenetics company in the wake of its first FDA approval, for Tazverik tazemetostat to treat epitheliod sarcoma (see "Epizyme Scores First FDA Approval").

Antibody-drug conjugate company ADC Therapeutics S.A. appointed Ron Squarer as chairman. He succeeds Peter Corr, who will remain on the board. Squarer was CEO of Array BioPharma Inc...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article